172 related articles for article (PubMed ID: 33396700)
21. Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.
Giustozzi M; Acciarresi M; Agnelli G; Caso V; Bandini F; Tsivgoulis G; Yaghi S; Furie KL; Tadi P; Becattini C; Zedde M; Abdul-Rahim AH; Lees KR; Alberti A; Venti M; D'Amore C; Giulia Mosconi M; Anna Cimini L; Bovi P; Carletti M; Rigatelli A; Cappellari M; Putaala J; Tomppo L; Tatlisumak T; Marcheselli S; Pezzini A; Poli L; Padovani A; Vannucchi V; Sohn SI; Lorenzini G; Tassi R; Guideri F; Acampa M; Martini G; Ntaios G; Athanasakis G; Makaritsis K; Karagkiozi E; Vadikolias K; Liantinioti C; Theodorou A; Halvatsiotis P; Mumoli N; Galati F; Sacco S; Tiseo C; Corea F; Ageno W; Bellesini M; Silvestrelli G; Ciccone A; Lanari A; Scoditti U; Denti L; Mancuso M; Ferrari E; Ulivi L; Orlandi G; Giannini N; Tassinari T; Luisa De Lodovici M; Rueckert C; Baldi A; Toni D; Letteri F; Giuntini M; Maria Lotti E; Flomin Y; Pieroni A; Kargiotis O; Karapanayiotides T; Monaco S; Maimone Baronello M; Csiba L; Szabó L; Chiti A; Giorli E; Del Sette M; Imberti D; Zabzuni D; Doronin B; Volodina V; Michel P; Vanacker P; Barlinn K; Barlinn J; Deleu D; Gourbali V; Paciaroni M; Masotti L
Stroke; 2020 Aug; 51(8):2347-2354. PubMed ID: 32646335
[TBL] [Abstract][Full Text] [Related]
22. Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program.
De Caterina R; Kim YH; Koretsune Y; Wang CC; Yamashita T; Chen C; Reimitz PE; Unverdorben M; Kirchhof P
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33546442
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
Saji N; Kimura K; Tateishi Y; Fujimoto S; Kaneko N; Urabe T; Tsujino A; Iguchi Y;
J Thromb Thrombolysis; 2016 Nov; 42(4):453-62. PubMed ID: 27207691
[TBL] [Abstract][Full Text] [Related]
24. Protocol for LASER: A Randomized Evaluation and an Associated Registry of Early Anticoagulation With Edoxaban After Ischemic Stroke in Patients With Atrial Fibrillation.
Alrohimi A; Jickling G; Jeerakathil T; Shuaib A; Khan K; Kate M; Hill MD; Buck B; Butcher K
Front Neurol; 2021; 12():645822. PubMed ID: 33868150
[No Abstract] [Full Text] [Related]
25. Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care.
Kirchhof P; Pecen L; Bakhai A; de Asmundis C; de Groot JR; Deharo JC; Kelly P; Levy P; Lopez-de-Sa E; Monteiro P; Steffel J; Waltenberger J; Weiss TW; Laeis P; Manu MC; Souza J; De Caterina R
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 9(1):47-57. PubMed ID: 35881467
[TBL] [Abstract][Full Text] [Related]
26. Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study.
De Caterina R; Kelly P; Monteiro P; Deharo JC; de Asmundis C; López-de-Sá E; Weiss TW; Waltenberger J; Steffel J; de Groot JR; Levy P; Bakhai A; Zierhut W; Laeis P; Reimitz PE; Kirchhof P;
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):97-104. PubMed ID: 30540648
[TBL] [Abstract][Full Text] [Related]
27. A Comparative Prospective Observational Study on the Use of Direct Oral Anticoagulants after Cardiac Surgery for the Management of Atrial Fibrillation.
Sezai A; Taoka M; Osaka S; Kitazumi Y; Suzuki K; Kamata K; Tanaka M
Ann Thorac Cardiovasc Surg; 2021 Jun; 27(3):191-199. PubMed ID: 33208579
[TBL] [Abstract][Full Text] [Related]
28. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.
Giugliano RP; Ruff CT; Rost NS; Silverman S; Wiviott SD; Lowe C; Deenadayalu N; Murphy SA; Grip LT; Betcher JM; Duggal A; Dave J; Shi M; Mercuri M; Antman EM; Braunwald E;
Stroke; 2014 Aug; 45(8):2372-8. PubMed ID: 24947287
[TBL] [Abstract][Full Text] [Related]
29. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
Best JG; Arram L; Ahmed N; Balogun M; Bennett K; Bordea E; Campos MG; Caverly E; Chau M; Cohen H; Dehbi HM; Doré CJ; Engelter ST; Fenner R; Freemantle N; Hunter R; James M; Lip GY; Murray ML; Norrving B; Sprigg N; Veltkamp R; Zaczyk I; Werring DJ;
Int J Stroke; 2022 Jun; 17(5):583-589. PubMed ID: 35018878
[TBL] [Abstract][Full Text] [Related]
30. Postmarketing surveillance on clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA-AF-Japan): Three-month interim analysis results.
Yamashita T; Koretsune Y; Ishikawa M; Shiosakai K; Kogure S
J Arrhythm; 2019 Feb; 35(1):121-129. PubMed ID: 30805052
[TBL] [Abstract][Full Text] [Related]
31. Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation.
Yamashita T; Koretsune Y; Yasaka M; Inoue H; Kawai Y; Yamaguchi T; Uchiyama S; Matsumoto M; Ogawa S
Circ J; 2012; 76(8):1840-7. PubMed ID: 22664798
[TBL] [Abstract][Full Text] [Related]
32. Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study.
Russo V; Attena E; Rago A; Melillo E; Di Micco P; Papa AA; Napolitano G; D'Onofrio A; Golino P; Nigro G
J Clin Med; 2020 May; 9(6):. PubMed ID: 32471222
[TBL] [Abstract][Full Text] [Related]
33. Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study.
de Groot JR; Weiss TW; Kelly P; Monteiro P; Deharo JC; de Asmundis C; López-de-Sá E; Waltenberger J; Steffel J; Levy P; Bakhai A; Zierhut W; Laeis P; Manu MC; Reimitz PE; De Caterina R; Kirchhof P
Eur Heart J Cardiovasc Pharmacother; 2021 Apr; 7(FI1):f30-f39. PubMed ID: 32790837
[TBL] [Abstract][Full Text] [Related]
34. Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE)-Trial design.
Colonna P; von Heymann C; Santamaria A; Matsushita Y; Unverdorben M
Clin Cardiol; 2018 Sep; 41(9):1123-1129. PubMed ID: 30069910
[TBL] [Abstract][Full Text] [Related]
35. Non-vitamin K oral anticoagulant use in the elderly: a prospective real-world study - data from the REGIstry of patients on Non-vitamin K oral Anticoagulants (REGINA).
Monelli M; Molteni M; Cassetti G; Bagnara L; De Grazia V; Zingale L; Zilli F; Bussotti M; Totaro P; De Maria B; Dalla Vecchia LA
Vasc Health Risk Manag; 2019; 15():19-25. PubMed ID: 30833810
[TBL] [Abstract][Full Text] [Related]
36. Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region.
Diaz AB; Chow J; Hoo FK; Koh KW; Lee GCK; Teo WS; Venketasubramanian N; Wang CC; Mehta R
Drugs Context; 2023; 12():. PubMed ID: 37711730
[TBL] [Abstract][Full Text] [Related]
37. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.
Bhatia K; Ladd LM; Carr KH; Di Napoli M; Saver JL; McCullough LD; Hosseini Farahabadi M; Alsbrook DL; Hinduja A; Ortiz Garcia JG; Sabbagh SY; Jafarli A; Divani AA
Curr Neurol Neurosci Rep; 2023 May; 23(5):235-262. PubMed ID: 37037980
[TBL] [Abstract][Full Text] [Related]
38. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
Yasaka M; Minematsu K; Yamaguchi T
Intern Med; 2001 Dec; 40(12):1183-8. PubMed ID: 11813841
[TBL] [Abstract][Full Text] [Related]
39. Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation.
Okumura K; Akao M; Yoshida T; Kawata M; Okazaki O; Akashi S; Eshima K; Tanizawa K; Fukuzawa M; Hayashi T; Akishita M; Lip GYH; Yamashita T;
N Engl J Med; 2020 Oct; 383(18):1735-1745. PubMed ID: 32865374
[TBL] [Abstract][Full Text] [Related]
40. Timing of Initiation of Oral Anticoagulation after Acute Ischemic Stroke in Patients with Atrial Fibrillation.
Smythe MA; Parker D; Garwood CL; Cuker A; Messé SR
Pharmacotherapy; 2020 Jan; 40(1):55-71. PubMed ID: 31698510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
